{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2940, 
        2954
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3114, 
        3128
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4127, 
        4150
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2848, 
        2875
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        453, 
        482
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2352, 
        2387
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2921, 
        2929
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3095, 
        3103
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3269, 
        3275
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3340, 
        3346
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3413, 
        3419
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3485, 
        3491
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3557, 
        3563
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2930, 
        2939
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3104, 
        3113
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3276, 
        3292
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3347, 
        3363
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3420, 
        3436
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3492, 
        3508
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3564, 
        3580
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2897, 
        2907
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3072, 
        3082
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3246, 
        3255
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3318, 
        3327
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3389, 
        3399
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3462, 
        3472
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3534, 
        3543
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3606, 
        3615
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3707, 
        3715
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3817, 
        3825
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3926, 
        3935
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4037, 
        4046
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2877, 
        2878
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160510161920|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&&ON^^^^JHN||XXXXX^XXXXXXX^XXXXXX||99999999|M|||99 XXXXXX XXXXXXXX^^XXXXXXXX^XX^X9X9X9^999|||||||||||||||||||N|\nOBR|1||BZ00604547|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160429|||62254^XXXX^XXXXX^^^XX.||||||||||||20160510|||F||||||||\n\n\n\n\n\n\n\nPath report.gross description\n\n1.Specimen consists of 1 tan tissue corenE\\measuring 7 mm and 2 fragments measuring in totalnE\\4 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\2.Specimen consists of 1 tan tissue corenE\\measuring 5 mm and 1 fragment measuring in totalnE\\4 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\3.Specimen consists of 1 tan tissue corenE\\measuring 17 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\4.Specimen consists of 1 tan tissue corenE\\measuring 12 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\5.Specimen consists of 1 tan tissue corenE\\measuring 8 mm and 1 fragment measuring in totalnE\\3 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\6.Specimen consists of 1 tan tissue corenE\\measuring 8 mm and 1 fragment measuring in totalnE\\3 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\7.Specimen consists of 1 tan tissue corenE\\measuring 11 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\8.Specimen consists of 1 tan tissue corenE\\measuring 15 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\9.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\10.Specimen consists of 1 tan tissue corenE\\measuring 9 mm and 2 fragments measuring in totalnE\\6 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\11.Specimen consists of 1 tan tissue corenE\\measuring 19 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\12.Specimen consists of 2 tan tissue coresnE\\measuring 7 and 15 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\\\n\n\nPath report.microscopic observation\n\nTumour TypenE\\Adenocarcinoma, conventional typenE\nE\\ExtentnE\\# sites involved/total sites  2 / 12nE\\# cores involved/total cores  2 / 12nE\\Overall % tissue involved  2.5%nE\\% involvement in mostnE\\extensively involved core  20%nE\nE\\GleasonnE\\Overall Gleason Score (1?, worst)7 (3, 4)nE\\Highest Gleason Score (any site)7 (3, 4)nE\\% Gleason patterns 4, 5  30%nE\nE\\OthernE\\Perineural invasion     Not identifiednE\\Periprostatic fat invasion  Not identifiednE\\\n\n\nPath report.final diagnosis\n\n1.BIOPSY, PROSTATE (RIGHT BASE LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 7/10 (PRIMARY 3, SECONDARY 4); 1/1 COREnE\\INVOLVED; 20% TISSUE INVOLVEMENT.nE\nE\\2.BIOPSY, PROSTATE (RIGHT BASE MEDIAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 7/10 (PRIMARY 3, SECONDARY 4); 1/1 COREnE\\INVOLVED; 10% TISSUE INVOLVEMENT.nE\nE\\3.BIOPSY, PROSTATE (RIGHT MID LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\4.BIOPSY, PROSTATE (RIGHT MID MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\5.BIOPSY, PROSTATE (RIGHT APEX LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\6.BIOPSY, PROSTATE (RIGHT APEX MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\7.BIOPSY, PROSTATE (LEFT BASE LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\8.BIOPSY, PROSTATE (LEFT BASE MEDIAL)nE\\- FOCAL CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\9.BIOPSY, PROSTATE (LEFT MID LATERAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\10.BIOPSY, PROSTATE (LEFT MID MEDIAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\11.BIOPSY, PROSTATE (LEFT APEX LATERAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\12.BIOPSY, PROSTATE (LEFT APEX MEDIAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\\\n\n\nPath report.relevant Hx\n\nPSA Total: 6.73 ng/mLnE\\Ratio: 0.17nE\nE\\Not providednE\\\n\n\n"
}